Michigan Medicine Halts Trans Youth Gender Care Under Trump Pressure
Under pressure from the Trump administration’s investigation into gender-affirming care for minors, Michigan Medicine announced it would halt the provision of hormone therapy and puberty blockers for patients under 19. This decision, prompted by federal subpoenas and escalating threats, has caused significant concern among parents and advocacy groups. The hospital system stated it will continue to offer other support services but is facing potential legal issues and civil rights violations. This comes amidst the backdrop of a broader national debate surrounding the legality and necessity of such care for transgender youth, with the American Medical Association and American Academy of Pediatrics supporting gender-affirming care.
John Q. Hosedrinker